Antonius van Dijk - Oct 13, 2021 Form 3 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Chief Technology Officer
Signature
/s/ Christine Klaskin, attorney-in-fact
Stock symbol
INKT
Transactions as of
Oct 13, 2021
Transactions value $
$0
Form type
3
Date filed
10/20/2021, 06:52 PM
Next filing
Jan 25, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INKT Stock Option (Right to Buy) Oct 13, 2021 Common Stock 83.5K $0.02 Direct F1
holding INKT Stock Option (Right to Buy) Oct 13, 2021 Common Stock 20.9K $0.02 Direct F2
holding INKT Stock Option (Right to Buy) Oct 13, 2021 Common Stock 20.9K $0.02 Direct F3
holding INKT Stock Option (Right to Buy) Oct 13, 2021 Common Stock 55.7K $0.01 Direct F4
holding INKT Stock Option (Right to Buy) Oct 13, 2021 Common Stock 55.7K $3.03 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an option to purchase shares of the common stock, which vests in four equal annual installments beginning on March 1, 2019.
F2 Represents an option to purchase shares of the common stock, which vests as to 30% of the underlying shares on November 19, 2021 and as to the remaining 70% of the underlying shares on November 19, 2022, in each case, generally subject to continued employment.
F3 Represents an option to purchase shares of the common stock, as determined by the achievement of certain milestones
F4 Represents an option to purchase shares of the common stock, which vests in four equal annual installments beginning on January 30, 2022.
F5 Represents an option to purchase shares of our common stock, which vests as to 33% of the underlying shares on February 11, 2022, and with respect to the remainder, in eight equal quarterly installments thereafter, in each case, generally subject to continued employment.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney